[1] |
CWinkelman WD, Elkadry E. An Evidenced-based Approach to Stress Urinary Incontinence in Women: What's New?[J]. Clin Obstet Gynecol, 2021, 64(2): 287-296.
|
[2] |
Milsom I, Altman D, Cartwright R, et al. Epidemiology of urinary incontinence (ui) and other lower urinary tract symptoms (luts), pelvic organ prolapse (pop) and anal incontinence (ai). in: abrams p, cardozo l, wagg a, wein a, eds. incontinence: 6th international consultation on incontinence[M]. 6th ed. Tokyo: International Continence Society (ICS) and International Consultation on Urological Diseases (ICUD), 2016, 1-141.
|
[3] |
Zhang RQ, Xia MC, Cui F, et al. Epidemiological survey of adult female stress urinary incontinence[J]. BMC Womens Health, 2021, 21(1): 172.
|
[4] |
朱兰,孙智晶. 女性压力性尿失禁诊断和治疗指南(2017)[J]. 中华妇产科杂志, 2017, 52(05): 289-293.
|
[5] |
Imamura M, Hudson J, Wallace SA, et al. Surgical interventions for women with stress urinary incontinence: systematic review and network meta-analysis of randomised controlled trials[J]. BMJ, 2019, 365: l1842.
|
[6] |
Lukacz ES, Santiago-Lastra Y, Albo ME, et al. Urinary Incontinence in Women: A Review[J]. JAMA, 2017, 318(16): 1592-1604.
|
[7] |
Rubilotta E, Balzarro M, D'Amico A, et al. Pure stress urinary incontinence: analysis of prevalence, estimation of costs, and financial impact[J]. BMC Urol, 2019, 19(1): 44.
|
[8] |
黄健. 中国泌尿外科和男科疾病诊断治疗指南: 2019版[M]. 北京: 人民卫生出版社, 2020: 346-347.
|
[9] |
National Institute for Health and Clinical Excellence. NICE guideline: Urinary incontinence and pelvic organ prolapse in women: management, 2019[EB/OL]. [Online]Available from:
URL
|
[10] |
徐净, 张奥华, 毛永江, 等. 膀胱颈移动度对女性压力性尿失禁患者的诊断价值[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2016, 10(1): 22-25.
|
[11] |
Osman NI, Li Marzi V, Cornu JN, et al. Evaluation and classification of stress urinary incontinence: current concepts and future directions[J]. Eur Urol Focus, 2016, 2(3): 238-244.
|
[12] |
Serati M, Braga A, Torella M, et al. The role of urodynamics in the management of female stress urinary incontinence[J]. Neurourol Urodyn, 2019, 38 Suppl 4: S42-S50.
|
[13] |
Finazzi-Agro E, Gammie A, Kessler TM, et al. Urodynamics useless in female stress urinary incontinence? time for some sense-a european expert consensus[J]. Eur Urol Focus, 2020, 6(1): 137-145.
|
[14] |
宋晓红,白文佩,朱兰,等. 肥胖女性压力性尿失禁体质量管理中国专家共识(2020版)[J]. 实用临床医药杂志, 2020, 24(2): 1-5.
|
[15] |
Fuselier A, Hanberry J, Margaret Lovin J, et al. Obesity and stress urinary incontinence: impact on pathophysiology and treatment[J]. Curr Urol Rep, 2018, 19(1): 10.
|
[16] |
Hay-Smith EJ, Herderschee R, Dumoulin C, et al. Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women[J]. Cochrane Database Syst Rev, 2011, 7(12): CD009508.
|
[17] |
Labrie J, Berghmans BL, Fischer K, et al. Surgery versus physiotherapy for stress urinary incontinence[J]. N Engl J Med, 2013, 369(12): 1124-1133.
|
[18] |
European Association of Urology. EAU Guidelines on Urinary Incontinence in Adults, 2020. [EB/OL]. Available from:
URL
|
[19] |
Weinstein MM, Pulliam SJ, Richter HE. Randomized trial comparing efficacy of pelvic floor muscle training with a digital therapeutic motion-based device to standard pelvic floor exercises for treatment of stress urinary incontinence (SUV trial): An all-virtual trial design[J]. Contemp Clin Trials, 2021, 105: 106406.
|
[20] |
Weber MA, Kleijn MH, Langendam M, et al. Local oestrogen for pelvic floor disorders: a systematic review[J]. PLoS One, 2015, 10(9): e0136265.
|
[21] |
Steinauer JE, Waetjen LE, Vittinghoff E, et al. Postmenopausal hormone therapy: does it cause incontinence?[J]. Obstet Gynecol, 2005, 106(5 Pt 1): 940-945.
|
[22] |
Lim R, Lee SW, Tan PY, et al. Efficacy of electromagnetic therapy for urinary incontinence: A systematic review[J]. Neurourol Urodyn, 2015, 34(8): 713-722.
|
[23] |
Lapii GA, Yakovleva AY, Neimark AI. Structural reorganization of the vaginal mucosa in stress urinary incontinence under conditions of Er:YAG laser treatment[J]. Bull Exp Biol Med, 2017, 162(4): 510-514.
|
[24] |
Hardy LA, Chang CH, Myers EM, et al. Computer simulations of thermal tissue remodeling during transvaginal and transurethral laser treatment of female stress urinary incontinence[J]. Lasers Surg Med, 2017, 49(2): 198-205.
|
[25] |
Blaganje M, Scepanovic D, Zgur L, et al. Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: A randomized controlled trial[J]. Eur J Obstet Gynecol Reprod Biol, 2018, 224: 153-158.
|
[26] |
Gonzalez Isaza P, Jaguszewska K, Cardona JL, et al. Long-term effect of thermoablative fractional CO2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause[J]. Int Urogynecol J, 2018, 29(2): 211-215.
|
[27] |
Lin KL, Chou SH, Long CY. Effect of Er:YAG Laser for Women with Stress Urinary Incontinence[J]. Biomed Res Int, 2019, 2019: 7915813.
|
[28] |
吕坚伟,吕婷婷,司俊文,等. 经尿道Er:YAG铒激光治疗女性轻中度压力性尿失禁的疗效分析[J]. 现代泌尿外科杂志, 2019, 24(4): 268-271.
|
[29] |
Dwyer PL, Karmakar D. Surgical management of urinary stress incontinence - Where are we now?[J]. Best Pract Res Clin Obstet Gynaecol, 2019, 54: 31-40.
|
[30] |
Serati M, Braga A, Athanasiou S, et al. Tension-free vaginal tape-obturator for treatment of pure urodynamic stress urinary incontinence: efficacy and adverse effects at 10-year follow-up[J]. Eur Urol, 2017, 71(4): 674-679.
|
[31] |
Nilsson CG, Palva K, Aarnio R, et al. Seventeen years' follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence[J]. Int Urogynecol J, 2013, 24(8): 1265-1269.
|
[32] |
Mostafa A, Lim CP, Hopper L, et al. Single-incision mini-slings versus standard midurethral slings in surgical management of female stress urinary incontinence: an updated systematic review and meta-analysis of effectiveness and complications[J]. Eur Urol, 2014, 65(2): 402-427.
|
[33] |
Hwang JC, Huang WC, Su TH, et al. Evaluation of efficacy and safety of single-incision sling versus transobturator sling in women with stress incontinence and intrinsic sphincter deficiency[J]. Int Urogynecol J, 2021. Online ahead of print.
|
[34] |
Rudnicki M, von Bothmer-Ostling K, Holstad A, et al. Adjustable mini-sling compared with conventional mid-urethral slings in women with urinary incontinence. A randomized controlled trial[J]. Acta Obstet Gynecol Scand, 2017, 96(11): 1347-1356.
|
[35] |
Alexandridis V, Rudnicki M, Jakobsson U, et al. Adjustable mini-sling compared with conventional mid-urethral slings in women with urinary incontinence: a 3-year follow-up of a randomized controlled trial[J]. Int Urogynecol J, 2019, 30(9): 1465-1473.
|
[36] |
Lapitan MCM, Cody JD, Mashayekhi A. Open retropubic colposuspension for urinary incontinence in women[J]. Cochrane Database Syst Rev, 2017, 7(7): CD002912.
|
[37] |
Fusco F, Abdel-Fattah M, Chapple CR, et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence[J]. Eur Urol, 2017, 72(4): 567-591.
|
[38] |
Mahdy A, Ghoniem GM. Autologous rectus fascia sling for treatment of stress urinary incontinence in women: a review of the literature[J]. Neurourol Urodyn, 2019, 38 Suppl 4: S51-S58.
|
[39] |
Brubaker L, Richter HE, Norton PA, et al. 5-year continence rates, satisfaction and adverse events of burch urethropexy and fascial sling surgery for urinary incontinence[J]. J Urol, 2012, 187(4): 1324-1330.
|
[40] |
Siddiqui ZA, Abboudi H, Crawford R, et al. Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review[J]. Int Urogynecol J, 2017, 28(9): 1275-1284.
|
[41] |
Ghoniem G, Farhan B, Chowdhury ML, et al. Safety and efficacy of polydimethylsiloxane (Macroplastique(R)) in women with stress urinary incontinence: analysis of data from patients who completed three years follow-up[J]. Int Urogynecol J, 2021, 32(10): 2835-2840.
|
[42] |
肖远松,胡卫列,吕军,等. 人工尿道括约肌植入术治疗骶髓损伤后压力性尿失禁[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2016, 10(1): 18-21.
|
[43] |
Ronzi Y, Le Normand L, Chartier-Kastler E, et al. Neurogenic stress urinary incontinence: is there a place for adjustable continence therapy (act and proact, uromedica, plymouth, mn, usa)? a retrospective multicenter study[J]. Spinal Cord, 2019, 57(5): 388-395.
|
[44] |
Klapper-Goldstein H, Tamam S, Sade S, et al. A systematic review of stem cell therapy treatment for women suffering from stress urinary incontinence[J]. Int J Gynaecol Obstet, 2021, Online ahead of print.
|
[45] |
Aragon IM, Imbroda BH, Lara MF. Cell Therapy Clinical Trials for Stress Urinary Incontinence: Current Status and Perspectives[J]. Int J Med Sci, 2018, 15(3): 195-204.
|
[46] |
Schmid FA, Williams JK, Kessler TM, et al. Treatment of stress urinary incontinence with muscle stem cells and stem cell components: chances, challenges and future prospects[J]. Int J Mol Sci, 2021, 22(8): 3981.
|
[47] |
Lee JY, Cannon TW, Pruchnic R, et al. The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence[J]. Int Urogynecol J Pelvic Floor Dysfunct, 2003, 14(1): 31-37.
|
[48] |
Eberli D, Aboushwareb T, Soker S, et al. Muscle precursor cells for the restoration of irreversibly damaged sphincter function[J]. Cell Transplant, 2012, 21(9): 2089-2098.
|
[49] |
Carr LK, Steele D, Steele S, et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence[J]. Int Urogynecol J Pelvic Floor Dysfunct, 2008, 19(6): 881-883.
|
[50] |
Stangel-Wojcikiewicz K, Jarocha D, Piwowar M, et al. Autologous muscle-derived cells for the treatment of female stress urinary incontinence: a 2-year follow-up of a Polish investigation[J]. Neurourol Urodyn, 2014, 33(3): 324-330.
|
[51] |
Sharifiaghdas F, Tajalli F, Taheri M, et al. Effect of autologous muscle-derived cells in the treatment of urinary incontinence in female patients with intrinsic sphincter deficiency and epispadias: A prospective study[J]. Int J Urol, 2016, 23(7): 581-586.
|
[52] |
Li M, Li G, Lei H, et al. Therapeutic potential of adipose-derived stem cell-based microtissues in a rat model of stress urinary incontinence[J]. Urology, 2016, 97: 277.e1-277.e7.
|
[53] |
Ni J, Li H, Zhou Y, et al. Therapeutic potential of human adipose-derived stem cell exosomes in stress urinary incontinence - an in vitro and in vivo study[J]. Cell Physiol Biochem, 2018, 48(4): 1710-1722.
|
[54] |
Wu R, Huang C, Wu Q, et al. Exosomes secreted by urine-derived stem cells improve stress urinary incontinence by promoting repair of pubococcygeus muscle injury in rats[J]. Stem Cell Res Ther, 2019, 10(1): 80.
|
[55] |
Zou XH, Zhi YL, Chen X, et al. Mesenchymal stem cell seeded knitted silk sling for the treatment of stress urinary incontinence[J]. Biomaterials, 2010, 31(18): 4872-4879.
|